HCPCS Level II drug code
J0690 — Injection, cefazolin sodium, 500 mg
In short
J0690 is the HCPCS Level II code for injection, cefazolin sodium, 500 mg. CMS assigns NDCs for Cefazolin Sodium and Cefazolin Sodium in Dextrose to it. One billing unit is 500 mg. The Medicare Part B payment limit is $0.781 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, cefazolin sodium, 500 mg
- Short descriptor
- Cefazolin sodium injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2000
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 500 mg. For example, 50000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J0690
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 37 NDCs to J0690 for Cefazolin Sodium and Cefazolin Sodium in Dextrose. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Cefazolin Sodium | 00143-9261-10 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 200 |
| Cefazolin Sodium | 00143-9262-25 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 50 |
| Cefazolin Sodium | 00143-9923-90 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 25 |
| Cefazolin Sodium | 00143-9924-90 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 50 |
| Cefazolin Sodium | 00143-9983-03 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 200 |
| Cefazolin Sodium | 00404-9833-99 | Henry Schein Inc. | 1 | 2 |
| Cefazolin Sodium | 00404-9834-99 | Henry Schein Inc. | 1 | 2 |
| Cefazolin Sodium | 00404-9835-99 | Henry Schein Inc. | 1 | 1 |
| Cefazolin Sodium | 00409-2585-01 | Pfizer Inc | 25 × 1 | 50 |
| Cefazolin Sodium | 00781-3450-95 | Sandoz Inc. | 10 × 1 | 10 |
| Cefazolin Sodium | 00781-3451-95 | Sandoz Inc. | 10 × 1 | 20 |
| Cefazolin Sodium | 00781-3451-96 | Sandoz Inc. | 25 × 10 | 50 |
| Cefazolin Sodium | 00781-3452-95 | Sandoz Inc. | 10 × 1 | 200 |
| Cefazolin Sodium | 25021-0100-10 | Sagent Pharmaceuticals | 25 × 1 | 25 |
| Cefazolin Sodium | 25021-0100-66 | Sagent Pharmaceuticals | 25 × 1 | 25 |
| Cefazolin Sodium | 25021-0101-10 | Sagent Pharmaceuticals | 25 × 1 | 50 |
| Cefazolin Sodium | 25021-0101-67 | Sagent Pharmaceuticals | 25 × 1 | 50 |
| Cefazolin Sodium | 25021-0102-69 | Sagent Pharmaceuticals | 10 × 1 | 200 |
| Cefazolin Sodium | 25021-0102-99 | Sagent Pharmaceuticals | 10 × 1 | 200 |
| Cefazolin Sodium | 44567-0120-25 | WG Critical Care, LLC | 25 × 1 | 50 |
| Cefazolin Sodium | 44567-0706-25 | WG Critical Care, LLC | 25 × 1 | 25 |
| Cefazolin Sodium | 44567-0707-25 | WG Critical Care, LLC | 25 × 1 | 50 |
| Cefazolin Sodium | 44567-0708-10 | WG Critical Care, LLC | 10 × 1 | 200 |
| Cefazolin Sodium | 50090-4256-00 | A-S Medication Solutions | 25 × 1 | 50 |
| Cefazolin Sodium | 60505-6142-05 | Apotex Corp | 25 × 1 | 50 |
| Cefazolin Sodium | 60505-6143-04 | Apotex Corp | 10 × 1 | 200 |
| Cefazolin Sodium | 60505-6231-05 | Apotex Corp | 25 × 1 | 100 |
| Cefazolin Sodium | 60505-6243-04 | Apotex Corp | 25 × 1 | 50 |
| Cefazolin Sodium | 60505-6244-04 | Apotex Corp | 10 × 1 | 200 |
| Cefazolin Sodium | 60505-6266-05 | Apotex Corp | 25 × 1 | 150 |
| Cefazolin Sodium | 63323-0237-10 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| Cefazolin Sodium | 63323-0238-61 | FreseniUS Kabi USA, LLC | 10 × 1 | 200 |
| Cefazolin Sodium | 72572-0055-25 | Civica, Inc. | 25 × 1 | 50 |
| Cefazolin Sodium | 72572-0056-10 | Civica, Inc. | 10 × 1 | 200 |
| Cefazolin Sodium in Dextrose | 00264-3103-11 | B. Braun Medical Inc. | 24 × 50 | 48 |
| Cefazolin Sodium in Dextrose | 00264-3105-11 | B. Braun Medical Inc. | 24 × 50 | 96 |
| Cefazolin Sodium in Dextrose | 00264-3107-11 | B. Braun Medical Inc. | 24 × 1 | 144 |
J0690: common questions
- Is J0690 a CPT code?
- No. J0690 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J0690?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 37 NDCs under J0690, for Cefazolin Sodium and Cefazolin Sodium in Dextrose. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J0690?
- $0.781 per 500 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J0690?
- One unit of J0690 is 500 mg, as stated in the code's descriptor. Units to report = dose given ÷ 500 mg. J-code billing units.